课题基金 / 基金详情

Economic Analysis of Anti-Rheumatic Medication in an Observational Cohort of Ontario Rheumatoid Arthritis Patients: Coverage with Evidence Development from the Ontario Best Practices Research Initiative

Economic Analysis of Anti-Rheumatic Medication in an Observational Cohort of Ontario Rheumatoid Arthritis Patients: Coverage with Evidence Development from the Ontario Best Practices Research Initiative
安大略省类风湿关节炎患者观察队列中抗风湿药物的经济分析：安大略省最佳实践研究计划证据开发的覆盖范围
批准号：
311841
负责人：
Tatangelo Mark R
金额：
$1.27万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-12-01 至 2014-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=311841&lang=en
关键词：
Chronic Diseases Coverage With Evidence Development Economic Analysis Economic Models Health Care Resource Utilization Health Services Research Observational Cohort Population Health Rheumatoid Arthritis

项目摘要

项目成果

Tatangelo Mark R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Biologic therapies are an expensive treatment for rheumatoid arthritis. Payers of rheumatoid arthritis medication cost including government, and private insurers make decisions on which drugs to pay for based on economic analysis to determine which drugs
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金